SCHEMBL20335254

SCHEMBL20335254

[O-][S+](c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1)c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK11 Q15759 17/20 0.79
MAPK14 Q16539 17/20 0.79
MAPK13 O15264 16/20 0.79
MAPK12 P53778 16/20 0.79
GCGR P47871 14/20 0.79
CSNK1A1 P48729 5/20 0.79
CSNK1D P48730 5/20 0.79
PRKD3 O94806 4/20 0.79
MAP4K4 O95819 4/20 0.79
FRK P42685 4/20 0.79
MAPK9 P45984 4/20 0.79
GSK3B P49841 4/20 0.79
CLK4 Q9HAZ1 3/20 0.79
PTK6 Q13882 3/20 0.79
PRKD2 Q9BZL6 3/20 0.79
ALOX5 P09917 13/20 0.71
ALDH1A1 P00352 4/20 0.70
RIPK2 O43353 3/20 0.70
CYP3A4 P08684 3/20 0.70
ALOX15 P16050 3/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sb-203580 SCHEMBL25800837 0.90 MAPK11 (0.75) MAPK11MAPK14MAPK13MAPK12GCGR
Sb-203580 SCHEMBL95208 0.90 MAPK11 (0.75) MAPK11MAPK14MAPK13MAPK12GCGR
SCHEMBL9192799 0.90 MAPK11 (0.75) MAPK11MAPK14MAPK13MAPK12GCGR
Sb-203580 SCHEMBL27075368 0.90 MAPK11 (0.75) MAPK11MAPK14MAPK13MAPK12GCGR
Sb-203580 SCHEMBL146399 0.90 MAPK11 (0.75) MAPK11MAPK14MAPK13MAPK12GCGR
Sb-203580 SCHEMBL220990 0.90 MAPK11 (0.75) MAPK11MAPK14MAPK13MAPK12GCGR
SCHEMBL15075603 0.89 MAPK11 (1.00) MAPK11MAPK14MAPK13MAPK12GCGR
SCHEMBL19868925 0.89 MAPK11 (1.00) MAPK11MAPK14MAPK13MAPK12GCGR
Sb-203580 SCHEMBL4890447 0.89 MAPK11 (0.73) MAPK11MAPK14MAPK13MAPK12GCGR
SCHEMBL6606221 0.87 MAPK11 (0.70) MAPK11MAPK14MAPK13MAPK12GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3342858-B1 ROR1-POSITIVE MESENCHYMAL STEM CELLS AND METHOD FOR PREPARING SAME, PHARMACEUTICAL COMPOSITION CONTAINING ROR1-POSITIVE MESENCHYMAL STEM CELLS AND METHOD FOR PREPARING SAME, AND METHOD FOR PREVENTING OR TREATING DISEASES BY USING ROR1-POSITIVE MESENCHYMAL STEM CELLS ROHTO PHARMA (JP) 2023-10-04 EP disclosed
US-11707488-B2 ROR1-positive mesenchymal stem cells and method for preparing same, pharmaceutical composition containing ROR1-positive mesenchymal stem cells and method for preparing same, and method for preventing or treating disease using ROR1-positive mesenchymal stem cells ROHTO PHARMACEUTICAL CO., LTD. (JP) 2023-07-25 US disclosed
CN-108350427-B ROR1 positive mesenchymal stem cells and pharmaceutical composition comprising same 日本乐敦制药株式会社 2022-03-11 CN disclosed
US-20200069740-A1 ROR1-POSITIVE MESENCHYMAL STEM CELL-CONTAINING PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DISEASE ASSOCIATED WITH FIBROSIS, METHOD FOR PREPARING SAME, AND METHOD FOR PREVENTING OR TREATING DISEASE ASSOCIATED WITH FIBROSIS USING ROR1-POSITIVE MESENCHYMAL STEM CELLS ROHTO PHARMACEUTICAL CO., LTD. (JP) 2020-03-05 US disclosed
US-20180333436-A1 ROR1-POSITIVE MESENCHYMAL STEM CELLS AND METHOD FOR PREPARING SAME, PHARMACEUTICAL COMPOSITION CONTAINING ROR1-POSITIVE MESENCHYMAL STEM CELLS AND METHOD FOR PREPARING SAME, AND METHOD FOR PREVENTING OR TREATING DISEASE USING ROR1-POSITIVE MESENCHYMAL STEM CELLS ROHTO PHARMACEUTICAL CO., LTD. (JP) 2018-11-22 US disclosed
EP-3342858-A1 ROR1-POSITIVE MESENCHYMAL STEM CELLS AND METHOD FOR PREPARING SAME, PHARMACEUTICAL COMPOSITION CONTAINING ROR1-POSITIVE MESENCHYMAL STEM CELLS AND METHOD FOR PREPARING SAME, AND METHOD FOR PREVENTING OR TREATING DISEASES BY USING ROR1-POSITIVE MESENCHYMAL STEM CELLS Rohto Pharmaceutical Co., Ltd. (JP) 2018-07-04 EP disclosed